Rohrer J W, Lynch R G
J Immunol. 1979 Sep;123(3):1083-7.
Tumor development, MOPC-315 stem cells, and M315-secretory cells were quantitated in carrier-primed BALB/c mice that had been challenged subcutaneously or i.v. with mixtures of TNP-carrier and TNP-binding MOPC-315 cells. We observed that tumor incidence, myeloma stem cells, and secretory myeloma cells were: i) suppressed in mice in whom carrier-specific suppressor T cells had previously been induced and ii) initially ehnahced in mice with carrier-specific helper T cells. The early enhancement in mice with carrier-specific helper T cells was followed by progressively declining myeloma stem cell frequencies and regression of established tumors. These studies demonstrate that T cell-derived immunoregulators of host origin can be focused onto localized and disseminated malignant B cells and specifically regulate the expansion and differentiation of the neoplastic clone.
在经载体致敏的BALB/c小鼠中,对肿瘤发展、MOPC - 315干细胞和M315分泌细胞进行了定量分析,这些小鼠经皮下或静脉注射TNP - 载体与TNP结合的MOPC - 315细胞混合物进行攻击。我们观察到,肿瘤发生率、骨髓瘤干细胞和分泌性骨髓瘤细胞:i)在先前已诱导出载体特异性抑制性T细胞的小鼠中受到抑制;ii)在具有载体特异性辅助性T细胞的小鼠中最初增强。具有载体特异性辅助性T细胞的小鼠早期增强之后,骨髓瘤干细胞频率逐渐下降,已形成的肿瘤消退。这些研究表明,宿主来源的T细胞衍生免疫调节因子可作用于局部和播散性恶性B细胞,并特异性调节肿瘤克隆的扩增和分化。